Cargando…
Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens
Patients affected by Inflammatory Bowel Disease (IBD) present higher risk for infection and suboptimal response upon vaccination. The immunogenicity of SARS-CoV2 vaccination is still largely unknown in adolescents or young adults affected by IBD (pIBD). We investigated the safety and immunogenicity...
Autores principales: | Cotugno, Nicola, Franzese, Enrica, Angelino, Giulia, Amodio, Donato, Romeo, Erminia Francesca, Rea, Francesca, Faraci, Simona, Tambucci, Renato, Profeti, Elisa, Manno, Emma Concetta, Santilli, Veronica, Rotulo, Gioacchino Andrea, Pighi, Chiara, Medri, Chiara, Morrocchi, Elena, Colagrossi, Luna, Pascucci, Giuseppe Rubens, Valentini, Diletta, Villani, Alberto, Rossi, Paolo, De Angelis, Paola, Palma, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318731/ https://www.ncbi.nlm.nih.gov/pubmed/35891273 http://dx.doi.org/10.3390/vaccines10071109 |
Ejemplares similares
-
Perinatally Human Immunodeficiency Virus–Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity( )
por: Morrocchi, Elena, et al.
Publicado: (2022) -
How CD4(+) T Cells Transcriptional Profile Is Affected by Culture Conditions: Towards the Design of Optimal In Vitro HIV Reactivation Assays
por: Pascucci, Giuseppe Rubens, et al.
Publicado: (2023) -
Two Pediatric Cases of Multisystem Inflammatory Syndrome with Overlapping Neurological Involvement Following SARS-CoV-2 Vaccination and Unknown SARS-CoV2 Infection: The Importance of Pre-Vaccination History
por: Santilli, Veronica, et al.
Publicado: (2022) -
Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies
por: Amodio, Donato, et al.
Publicado: (2021) -
Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome
por: Valentini, Diletta, et al.
Publicado: (2022)